Lloyd Price
FEBRUARY 18, 2024
HealthTech M&A Soft Landing Areas: Digital therapeutics: Growing demand for personalised, data-driven treatments creates opportunities for companies with proven solutions. Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable.
Lloyd Price
FEBRUARY 2, 2024
Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
FEBRUARY 22, 2024
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
The Digital Health Corner
MARCH 26, 2018
Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health. According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, health information interoperability is facilitated with the use of blockchain.
Lloyd Price
APRIL 29, 2024
Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.
Expert insights. Personalized for you.
64 
Let's personalize your content